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Abstract
Background: Quantitative measures of 11C-raclopride receptor binding can be used as a correlate of postsynaptic
D2 receptor density in the striatum, allowing
11C-raclopride positron emission tomography (PET) to be used for the
differentiation of Parkinson’s disease from atypical parkinsonian syndromes. Comparison with reference values is
recommended to establish a reliable diagnosis. A PET template specific to raclopride may facilitate direct
computation of parametric maps without the need for an additional MR scan, aiding automated image analysis.
Methods: Sixteen healthy volunteers underwent a dynamic 11C-raclopride PET and a high-resolution T1-weighted
MR scan of the brain. PET data from eight healthy subjects was processed to generate a raclopride-specific PET
template normalized to standard space. Subsequently, the data processing based on the PET template was
validated against the standard magnetic resonance imaging (MRI)-based method in 8 healthy subjects and 20
patients with suspected parkinsonian syndrome. Semi-quantitative image analysis was performed in Montreal
Neurological Institute (MNI) and in original image space (OIS) using VOIs derived from a probabilistic brain atlas
previously validated by Hammers et al. (Hum Brain Mapp, 15:165–174, 2002).
Results: The striatal-to-cerebellar ratio (SCR) of 11C-raclopride uptake obtained using the PET template was in
good agreement with the MRI-based image processing method, yielding a Lin’s concordance coefficient of 0.87.
Bland-Altman analysis showed that all measurements were within the ±1.96 standard deviation range. In all 20
patients, the PET template-based processing was successful and manual volume of interest optimization had no
further impact on the diagnosis of PD in this patient group. A maximal difference of <5% was found between the
measured SCR in MNI space and OIS.
Conclusions: The PET template-based method for automated quantification of postsynaptic D2 receptor density
is simple to implement and facilitates rapid, robust and reliable image analysis. There was no significant difference
between the SCR values obtained with either PET- or MRI-based image processing. The method presented alleviates
the clinical workflow and facilitates automated image analysis.
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Background
Positron emission tomography (PET) with 11C-raclopride
is used for the differentiation of Parkinson’s disease (PD)
from atypical parkinsonian syndromes [1]. In early stages
of PD, the postsynaptic D2 receptor density is upregulated
whereas in atypical parkinsonian syndromes, i.e. multiple
system atrophy (MSA), progressive supranuclear palsy
(PSP) and corticobasal degeneration (CBD), a normal or
decreased receptor density is found [2]. As a correlate of
postsynaptic D2 receptor density in the putamen and
caudate nucleus (striatum), quantitative measures of
11C-raclopride binding, combined with comparison to ref-
erence values, are recommended for reliable diagnosis [3].
Region-based methods for PET quantification are
widely used and have been shown to yield reliable results
[4]. However, manual delineation of regions of interest
(ROIs) or volumes of interest (VOIs) are user-dependent
and time-consuming. Furthermore, these techniques
introduce intra- and interoperator variation, which limits
the reproducibility of the results. Several atlas-based
methods function through normalization of correspond-
ing MR images into a stereotaxic spatial array and appli-
cation of the same transformation to the co-registered
PET images [5]. A challenge often encountered is that
the normalization of subcortical regions and particularly
the striatum is prone to errors, mainly due to differences
in the morphology of the ventricular system. Thus, sub-
cortical VOIs often had to be user-adjusted. Further-
more, where PET tracer uptake is limited to discrete
regions, as for 11C-raclopride, co-registration of the PET
image to the corresponding MR image may be inaccur-
ate. Dynamic scanning can provide perfusion-like data
immediately after tracer injection which can be used for
more accurate PET to MR co-registration, at the cost of
increased scan time [6,7]. Advanced magnetic resonance
imaging (MRI)-based VOI definition methods use com-
puter vision techniques for the segmentation of the de-
sired structures. Yasuno et al. [8] utilized MR images to
determine the probabilities of grey matter to refine the
ROIs. Svarer et al. [9] reduced the individual variability
by applying a warping algorithm to several segmented
brains to estimate probabilistic ROIs for an individual
brain. An even more sophisticated technique was applied
by Rusjan et al. [10], using the Montreal Neurological
Institute/International Consortium of Brain Mapping
standard brain template (MNI/ICBM), segmentation
using a fitting function of grey matter probability and
multiple iterations of morphological dilatation to prevent
overlap between neighbouring ROIs [10].
A number of approaches based on ligand-specific tem-
plates have already been assessed with promising results
for further development of automated data processing
and image analysis [11-13]. However, there is an ongoing
discussion if measurements made in the MNI space are
as reliable as the measurement made in the subject’s
original image space (OIS), as different transformations
and interpolations have been applied to the image data.
A raclopride template could make direct computation of
parametric maps in standard or original imaging space
possible without the need for early time frames in PET
and an additional MR scan. This would facilitate efficient
clinical workflow and automated image analysis.
Methods
A total of 16 healthy volunteers (mean age 45, range 25
to 70; all females) and 20 consecutive patients with sus-
pected parkinsonian syndrome (mean age 60, range 45
to 81; 9 females, 11 males) were included. All volunteers
underwent a dynamic 11C-raclopride PET (0 to 60 min
postinjection (p.i.)) and a high-resolution MR scan of
the brain (details below). All patients underwent a static
11C-raclopride PET scan (40 to 60 min p.i.). The study
was approved by the institutional ethics committee of
the canton of Zurich, Switzerland, and written informed
consent was obtained from all participants.
PET and MR data acquisition
11C-raclopride was produced on site according to GMP
guidelines. The PET examinations were performed on a
full ring PET/CT scanner with an axial field of view of
15.3 cm in three-dimensional (3D) mode (Discovery
STE, GE Healthcare, Waukesha, WI, USA). The emis-
sion data was corrected for attenuation using the
corresponding CT (120 kV/80 mA). The PET images
were reconstructed using a standard iterative algorithm
(ordered set expectation maximization (OSEM)) by inte-
grating further correction algorithms to reduce image
noise caused by scatters and randoms. The dynamic
PET scan was started immediately after bolus injection
of 250 MBq 11C-raclopride, and emission data was ac-
quired over 60 min with frame durations of 1 min (0 to
15 min p.i.) and 5 min (15 to 60 min p.i.). Static PET ac-
quisition was performed 40 to 60 min after tracer injec-
tion. Volumetric MR data was acquired in the transverse
plane using a T1-weighted 3D gradient echo MR pulse
sequence with isotropic voxels (1 mm). MR scan param-
eters were as follows: field strength, 3 T; time of repeti-
tion (TR), 8.8 ms; time of echo (TE), 2.3 ms; flip angle,
8° and number of excitations (NEX), 1.
Image processing and analysis
All data processing was performed using PMOD Version
3.4 (PMOD Technologies Ltd., Zurich, Switzerland).
Two approaches to spatial normalization were investi-
gated: MRI-based and PET template-based (Figure 1).
The early PET frames (1 to 8 min p.i.) reflecting cerebral
blood flow were averaged to obtain a perfusion-like
image. Individual raclopride binding images from healthy
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volunteer dynamic data were generated by averaging the
PET frames acquired between 40 and 60 min after tracer
injection. Averaging of multiple frames was performed
to obtain images with a high signal-to-noise ratio (SNR).
Motion correction based on a reference frame (10 to
15 min p.i.) was performed on all dynamic PET frames
to correct for minor subject movements during the
emission scan.
MRI-based spatial normalization
Rigid image co-registration of PET to MRI. The perfusion-
like images generated from dynamic data in healthy
volunteers outlining the cortical and subcortical grey matter
were co-registered to the corresponding 3D T1w MR im-
ages by applying a normalized mutual-information-based
rigid registration. The resulting transformation matrix was
applied to the corresponding binding images.
Spatial normalization of MRI. Normalization of the
MRI images to a T1 MR template image matching the
MNI stereotaxic space (identical to the T1 template pro-
vided with SPM5, derived from the ICBM152 image)
was performed using an SPM5 compliant procedure
with 16 iterations and a cutoff of 25.
Spatial normalization of PET. The transformation
matrices of the rigid registration of PET to MRI and the
elastic registration of MRI to stereotaxic MNI space
were combined to normalize the PET binding images
into the MNI space.
PET template-based spatial normalization
Generation of the PET template. Spatially normalized
binding images from eight independent healthy subjects
were averaged to obtain a high SNR raclopride PET tem-
plate. To ensure that the eight subjects contributed
equally to the final template, the mean activity in the
basal ganglia was normalized to a value of 1.
Spatial normalization of PET images to raclopride PET
template. Raclopride binding images were directly
transformed into MNI space by normalization to the
raclopride PET template with the same parameters as
described for the MRI normalization.
Quantitative VOI analysis
Following normalization, the maximum probability atlas
(Hammers N30R83) was intersected with the 50% grey
matter probability map and used for VOI definition. The
construction of the N30R83 atlas and the segmentation
algorithm has been described elsewhere [5,14].
Subsequently, the measured radioactivity in all voxels
was divided by the mean activity in the cerebellum
(reference region) to standardize for levels of free tracer.
11C-raclopride uptake in striatal VOIs was quantified,
Figure 1 Normalization of the binding PET images. (A) Rigid co-registration of perfusion-like PET images to MRI (transformation matrix t1).
Spatial normalization of MR images in original image space (OIS) into MNI space (t2). Combination of t1 and t2 to normalize the binding PET
images into the MNI space. (B) Direct transformation of binding PET images to MNI space by normalization to the raclopride PET template.
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including the caudate nucleus and the putamen
(Figure 2). The analysis was performed in both MNI
space and the subject’s OIS, due to potential concerns
regarding the correctness of the measurements after data
transformation and interpolation during the spatial
normalization procedure. The atlas-based VOIs were
transformed into OIS using the inverse of the combined
transformation matrices. The percentage difference be-
tween the activity concentration measured in the MNI
space and in OIS was computed according to the follow-
ing formula:
Difference% ¼ SCR MNIð Þ
SCR OISð Þ –1
 
 100%
where the striatal-cerebellar ratio (SCR) indicates the
normalized mean tissue radioactivity concentration in
the striatum.
Validation with patient data
Static raclopride PET binding images from 20 patients
with suspected parkinsonian syndrome were normalized
to MNI space using the PET template. Following
normalization, the maximum probability atlas (Hammers
N30R83) was applied for VOI definition. As a standard
of reference, the definition of the atlas VOIs was verified
in three orthogonal image planes by an experienced
nuclear medicine physicist and manually optimized if
necessary. The data was analyzed in both MNI space
and OIS.
Image findings supporting the diagnosis of PD are in-
creased raclopride-uptake contralateral to the dominant
clinical symptoms and a high Z-score compared to the
reference population (Figure 3).
Statistical evaluation
Statistical analysis was performed using SPSS (SPSS
Version 20, IBM Corporation, Armonk, NY, USA). The
degree of agreement between the MR and PET template
method was analyzed by using Bland-Altman plots and
by calculating the Lin’s concordance coefficient.
For the global statistical assessment, the right and left
striatum were analyzed separately. For the comparison of
the measurements in MNI and OIS, the caudate nucleus
and the putamen from left and right were assessed together.
Results
All PET and MR images of the 16 healthy subjects were
of high quality and were included for further evaluation.
In 12 out of the 20 patients, PD was confirmed by raclo-
pride imaging and clinical 1 year follow-up. The other
eight patients were diagnosed with essential tremor. No
patients with MSA, PSP or CBD were in the study
population.
Figure 2 Maximum probability atlas (Hammers N30R83) for
VOI definition.
Figure 3 Patient with parkinsonian syndrome. With clinical
symptoms predominantly on the right side and pronounced
increase of raclopride uptake on the contralateral left side. Z score,
Caudate nucleus right, 2.5 and left, 3.0. Putamen right, 4.9 and
left, 6.0.
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Comparing the MR and PET template-based spatial
normalization methods, there was a high degree of con-
cordance between the measured tissue concentrations in
the caudate nucleus and the putamen in MNI space with
a Lin’s concordance coefficient (ρc) of 0.87 including an
upper one-sided 95% confidence interval of ρc = 0.93 and
a lower one-sided 95% confidence interval of ρc = 0.79
[15]. Bland-Altman analysis indicated that all measure-
ments were within the ±1.96 standard deviation range
(Figure 4) without evidence of systematic bias (standard
deviation 0.36, absolute values for the limits of agree-
ment +0.63 and −0.64).
Based on the MRI approach, the maximal difference
between the measurements in MNI space and after
back-transformation to the OIS was 4.3% in the caudate
nucleus (mean 0.3, standard deviation 2.4) and 4.2% in
the putamen (mean 0.2, SD 2.2). The direct approach
based on the PET template yielded a maximal difference
between the measurements in MNI or OIS of 2.2% in
the caudate nucleus (mean −0.8, SD 1.4) and 3.7% in the
putamen (mean −1.2, SD 1.4) (Figure 5). No significant
difference (paired t test) between the measurements in
MNI space or OIS was found, with p = 0.72.
PET template-based processing was successful in all
20 patients. Image analysis resulted in diagnosis of PD in
12 patients, and further analysis of SCR was only per-
formed in those 12 patients. The maximal difference
between measurements with automated VOI placement
and after manual VOI optimization (standard of refer-
ence) was 4.5% (mean 0.6%, SD 1.9), which had no
impact on the diagnosis of PD in this patient subgroup.
Discussion
A raclopride binding PET template generated using
dynamic PET data from healthy volunteers facilitated
direct quantification of 11C-raclopride binding in the
putamen and caudate nucleus (striatum). Quantitative
measures of D2 receptor density with comparison to ref-
erence values are recommended for the detection of the
early stages of movement disorders and establishment of
a reliable diagnosis.
Raclopride binding is typically assessed between 40 to
60 min after tracer injection, once free tracer has cleared
from the blood pool. However, at this time point, tracer
binding is limited to D2 receptor dense regions, namely
the caudate nucleus and putamen, making automatic co-
registration of the PET data to the corresponding MR
highly inaccurate. Perfusion-like images from early time
frames of PET imaging are more suitable for image
co-registration with morphological MRI [6,7]. However,
the need for MR images and full dynamic PET series in
addition to receptor binding images from late time
frames in PET is not cost-effective in a clinical setting.
Extra image processing are necessitated which may be
less readily automated.
Figure 4 Bland-Altman plot comparing the measurements of the two approaches (SD = 0.36).
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The sophisticated MR postprocessing technique ap-
plied in the present study used a combination of grey
matter segmentation, a probabilistic atlas and a mutual
information-based normalization process to achieve ac-
curate image co-registration to the MNI/ICBM standard
brain template. Automated analysis of quantitative PET
data requires robust image processing with a minimum
number of opportunities to introduce errors [16]. Tech-
niques based on MRI require high-quality images to
ensure correct segmentation and normalization, which is
not always straightforward in patients with movement dis-
orders. As manually optimized VOIs are user-dependent
and time-consuming, they do not represent an ideal alter-
native to atlas-based measurements.
The PET raclopride binding template allows for direct
computation of SCR parametric maps after a single
normalization step. This procedure facilitates automated
data processing and image analysis. One-step co-
registration of raclopride binding images to the binding
template may also reduce the risks of errors introduced
in the multi-step MR-based process. Furthermore, user-
independent data quantification reduces intra- and inter-
operator variations which can otherwise limit the repro-
ducibility of the measurements. Direct normalization of
the PET data obviates the need for the acquisition of
early PET frames in a dynamic protocol and for an
additional MR scan. Patients must thus spend less time
in the scanner, improving patient comfort and cost-
effectiveness in clinical routine. Taken together, the
development of a PET binding template and the use of
one-step brain normalization suggest that a total image
acquisition time of about 10 to 20 min could be suffi-
cient to establish a reliable diagnosis in patients with
parkinsonian syndrome.
As an initial validation of the PET-template based
image processing protocol, we applied it in a small
cohort of patients. Direct image normalization using the
PET template was successful in all cases, and further
analysis of the PD diagnosed subgroup indicated that
quantitative measurements of 11C-raclopride binding
were within 5% of the values from manually defined
VOIs (standard of reference). This level of variation was
not sufficient to influence diagnosis of PD and supports
the use of static PET 11C-raclopride imaging without
MR in the clinic.
The calculation of PET VOI statistics can be per-
formed in both the original image space and after
normalization to the MNI space. In order to examine
the effect of interpolation of the original PET values
during transformation, the atlas-based VOIs were back-
transformed to the original PET image space (OIS). The
maximal difference in SCR between the measurements
in MNI template space and in OIS was found to be <5%,
suggesting that either measurement should be suitable
for the quantification of clinical data. No systemic meas-
urement errors with significantly higher or lower quanti-
tative values in OIS or MNI were found. The slight
tendency to higher quantitative measurements in OIS
when using the PET template method might be ex-
plained by the smoothing and interpolation process
during image normalization into MNI space. These
results may legitimate the direct measurements in the
Figure 5 Percentage difference of quantitative measurement in MNI space and in original image space. Based on the MRI method or the
generated PET template (CN, caudate nucleus; P, putamen).
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MNI space which is more easily implemented in an
automated image analysis procedure.
In line with a previous study by Meyer et al. [11], we
found that the ligand template method provides a reliable
approach for spatial normalization of PET ligand images.
We confirmed these results by using perfusion-like
early raclopride frames to assure the most accurate co-
registration of the PET and MRI data and by applying
advanced spatial normalization techniques especially
suited for the normalization of the basal ganglia. Further-
more, we used an atlas-based approach eliminating the
user-dependent and time-consuming VOI delineation.
Conclusions
A PET template-based method for automated quantifi-
cation of postsynaptic D2 receptor density is simple to
implement and allows for rapid, robust and reliable
image analysis. There was no significant difference
between the SCR values obtained using this method and
the more demanding MR-based image processing. The
method presented simplifies the clinical workflow and
facilitates automated image analysis.
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